GLP1R and thyroid cancer: In contrast to this study, a meta-analysis by Silverii et al. reported that GLP-1R therapy use was associated with a significantly greater risk for overall thyroid cancer in a fixed-effect analysis (44); however, a fragility index of 1 was noted, meaning that it would take only one additional case of thyroid cancer in the comparator group for the association to lose significance.